JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RNLX
4851
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $196K | ﹤0.01% |
80,913
-1,255
| -2% | -$3.48K |
2021 Q1
8 quarters
|
|
4852
Innovator US Equity Ultra Buffer ETF March
UMAR
$143M
| $195K | ﹤0.01% |
+6,800
| New | +$192K |
2023 Q1
0 quarters
|
|
4853
Virginia National Bankshares
VABK
$259M
| $194K | ﹤0.01% |
+5,400
| New | +$203K |
2023 Q1
0 quarters
|
|
|
LMST
4854
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
| $194K | ﹤0.01% |
8,708
+8,700
| +108,750% | +$219K |
2020 Q2
11 quarters
|
|
|
VIA
4855
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $193K | ﹤0.01% |
10,520
-97,143
| -90% | -$2.74M |
2014 Q4
33 quarters
|
|
4856
Franklin FTSE Australia ETF
FLAU
$213M
| $193K | ﹤0.01% |
7,187
+138
| +2% | +$3.79K |
2022 Q4
1 quarter
|
|
4857
FT Vest International Equity Buffer ETF September
YSEP
$127M
| $193K | ﹤0.01% |
10,027
| – | – |
2022 Q4
1 quarter
|
|
4858
Alerus Financial
ALRS
$808M
| $191K | ﹤0.01% |
11,893
+30
| +0.3% | +$594 |
2019 Q4
13 quarters
|
|
4859
John Marshall Bancorp
JMSB
$325M
| $191K | ﹤0.01% |
8,861
+170
| +2% | +$4.22K |
2022 Q2
3 quarters
|
|
4860
Vuzix
VUZI
$252M
| $191K | ﹤0.01% |
46,125
+1,918
| +4% | +$8.63K |
2020 Q4
9 quarters
|
|
4861
Monte Rosa Therapeutics
GLUE
$845M
| $190K | ﹤0.01% |
24,400
+6,064
| +33% | +$42.2K |
2021 Q3
6 quarters
|
|
|
IGMS
4862
DELISTED
IGM Biosciences
IGMS
| $190K | ﹤0.01% |
13,800
+2,585
| +23% | +$53.5K |
2019 Q4
13 quarters
|
|
4863
Live Ventures
LIVE
$23.3M
| $190K | ﹤0.01% |
6,000
| – | – |
2021 Q1
8 quarters
|
|
4864
Colony Bankcorp
CBAN
$432M
| $189K | ﹤0.01% |
18,544
+2,799
| +18% | +$34K |
2019 Q1
16 quarters
|
|
4865
Home Bancorp
HBCP
$530M
| $189K | ﹤0.01% |
5,727
-691
| -11% | -$26.1K |
2017 Q3
22 quarters
|
|
4866
Prospect Capital
PSEC
$966M
| $189K | ﹤0.01% |
27,211
-26,187
| -49% | -$190K |
2015 Q2
31 quarters
|
|
|
NGMS
4867
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $189K | ﹤0.01% |
12,417
-3,509
| -22% | -$49.4K |
2021 Q1
8 quarters
|
|
4868
Northern Trust STOXX Global Broad Infrastructure ETF
NFRA
$3B
| $189K | ﹤0.01% |
3,635
+3,512
| +2,855% | +$181K |
2021 Q1
8 quarters
|
|
4869
Teucrium Corn Fund
CORN
$132M
| $188K | ﹤0.01% |
7,458
-5,634
| -43% | -$145K |
2016 Q2
27 quarters
|
|
4870
Tarsus Pharmaceuticals
TARS
$3.5B
| $188K | ﹤0.01% |
14,969
+3,618
| +32% | +$52.9K |
2020 Q4
9 quarters
|
|
4871
Global X S&P 500 Covered Call ETF
XYLD
$3.41B
| $188K | ﹤0.01% |
4,635
+432
| +10% | +$17.4K |
2022 Q1
4 quarters
|
|
4872
Advantage Solutions
ADV
$356M
| $187K | ﹤0.01% |
4,714
+111
| +2% | +$6.27K |
2020 Q1
12 quarters
|
|
|
BRT
4873
BRT Apartments
BRT
$257M
| $187K | ﹤0.01% |
9,447
-3,440
| -27% | -$70K |
2018 Q2
19 quarters
|
|
4874
Universal Technical Institute
UTI
$1.07B
| $187K | ﹤0.01% |
25,373
+6,622
| +35% | +$47.2K |
2020 Q1
12 quarters
|
|
4875
iShares Global Consumer Staples ETF
KXI
$1.12B
| $187K | ﹤0.01% |
3,016
+2,881
| +2,134% | +$172K |
2020 Q1
12 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.